Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.
| Fund | Change | Quarter |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | VANGUARD CAPITAL MANAGEMENT LLC opened a new position worth $11,409,306. | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | RENAISSANCE TECHNOLOGIES LLC exited a position previously worth $384,051. | 2026-06-30 |
| Sanofi | Sanofi reduced this position by 24% ($17,822,318 -> $13,515,709). | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | MILLENNIUM MANAGEMENT LLC reduced this position by 72% ($5,811,292 -> $1,648,706). | 2026-06-30 |
| DCF Advisers, LLC | DCF Advisers, LLC increased this position by 429% ($745,505 -> $3,942,100). | 2026-06-30 |
| LEVIN CAPITAL STRATEGIES, L.P. | LEVIN CAPITAL STRATEGIES, L.P. increased this position by 3820% ($52,700 -> $2,065,860). | 2026-06-30 |
| FMR LLC | FMR LLC reduced this position by 7% ($30,080,891 -> $27,880,797). | 2026-06-30 |
| ALETHEA CAPITAL MANAGEMENT, LLC | ALETHEA CAPITAL MANAGEMENT, LLC increased this position by 1853% ($120,867 -> $2,359,946). | 2026-06-30 |
Largest reported positions as of 2026-06-30.
| Fund | Value | Shares |
|---|---|---|
| FMR LLC | $27,880,797 | 5,587,334 |
| Sanofi | $13,515,709 | 2,708,559 |
| VANGUARD CAPITAL MANAGEMENT LLC | $11,409,306 | 2,286,434 |
| DCF Advisers, LLC | $3,942,100 | 790,000 |
| Connor, Clark & Lunn Investment Management Ltd. | $3,000,262 | 601,255 |
| ALETHEA CAPITAL MANAGEMENT, LLC | $2,359,946 | 472,935 |
| Summit Financial, LLC | $2,256,797 | 452,264 |
| LEVIN CAPITAL STRATEGIES, L.P. | $2,065,860 | 414,000 |
| UBS Group AG | $1,999,278 | 400,657 |
| VANGUARD FIDUCIARY TRUST CO | $1,800,212 | 360,764 |
Data compiled from public SEC filings. This is informational reporting, not investment advice.
This page tracks Sanofi’s institutional portfolio activity as disclosed in its quarterly Form 13F filings with the SEC. Rather than a one-off news snapshot, think of it as a running ledger — new positions, exits, and size changes get logged here every quarter so you can see how the company’s biotech and pharma stakes shift … Read more
Blue Owl Capital Holdings LP’s portfolio moves, tracked quarter by quarter, based on its SEC Form 13F filings. These filings offer a quarterly snapshot of U.S. equity holdings for institutional investment managers, revealing what a fund added, trimmed, or exited entirely. They do not show exact trade dates or the reasoning behind a move, but … Read more